BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1341908)

  • 1. Bioreductive drugs in cancer therapy.
    Stratford IJ
    BJR Suppl; 1992; 24():128-36. PubMed ID: 1341908
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioreductive therapy.
    Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1992; 22(4):685-7. PubMed ID: 1544837
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
    Adams GE; Stratford IJ; Edwards HS; Bremner JC; Cole S
    Int J Radiat Oncol Biol Phys; 1992; 22(4):717-20. PubMed ID: 1544844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The experimental development of bioreductive drugs and their role in cancer therapy.
    Workman P; Stratford IJ
    Cancer Metastasis Rev; 1993 Jun; 12(2):73-82. PubMed ID: 8375022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
    Adams GE; Stratford IJ; Bremner JC; Edwards HS; Fielden EM
    Radiother Oncol; 1991; 20 Suppl 1():85-91. PubMed ID: 2020774
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioreductive therapies: an overview of drugs and their mechanisms of action.
    Rauth AM; Melo T; Misra V
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):755-62. PubMed ID: 9845091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic sensitizer and cytotoxin for head and neck cancer.
    Lee DJ; Moini M; Giuliano J; Westra WH
    Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioreductive drugs and the selective induction of tumour hypoxia.
    Bremner JC; Stratford IJ; Bowler J; Adams GE
    Br J Cancer; 1990 May; 61(5):717-21. PubMed ID: 2110814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia: targeting the tumour.
    Boyle RG; Travers S
    Anticancer Agents Med Chem; 2006 Jul; 6(4):281-6. PubMed ID: 16842231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioreductive drugs for cancer therapy: the search for tumor specificity.
    Adams GE; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):231-8. PubMed ID: 8195012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitisers to radiation-activated prodrugs.
    Shibamoto Y; Sugie C; Ito M; Ogino H
    Expert Opin Pharmacother; 2004 Dec; 5(12):2459-67. PubMed ID: 15571464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypobaric hypoxia: a method for testing bioreductive drugs in vivo.
    McAleer JJ; McKeown SR; MacManus MP; Lappin TR; Bridges JM
    Int J Radiat Oncol Biol Phys; 1992; 23(3):551-5. PubMed ID: 1612955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting bioreductive drugs to tumours: is it necessary to manipulate blood flow?
    Brown JM
    Int J Radiat Biol; 1991; 60(1-2):231-6. PubMed ID: 1677976
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of radioimmunotherapy in combination with bioreductive agents.
    Langmuir VK
    Recent Results Cancer Res; 1996; 141():137-43. PubMed ID: 8722424
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving the effectiveness of the bioreductive antitumor agent SR 4233 by induced hypoxia.
    Minchinton AI; Brown JM
    Adv Exp Med Biol; 1992; 317():177-81. PubMed ID: 1288125
    [No Abstract]   [Full Text] [Related]  

  • 16. Tirapazamine: from bench to clinical trials.
    Marcu L; Olver I
    Curr Clin Pharmacol; 2006 Jan; 1(1):71-9. PubMed ID: 18666379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreductive mechanisms.
    Workman P
    Int J Radiat Oncol Biol Phys; 1992; 22(4):631-7. PubMed ID: 1544830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bioreductive drugs in multicell spheroids.
    Durand RE; Olive PL
    Int J Radiat Oncol Biol Phys; 1992; 22(4):689-92. PubMed ID: 1544838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment and the response to anticancer therapy.
    Brown JM
    Cancer Biol Ther; 2002; 1(5):453-8. PubMed ID: 12496469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of radiobiological hypoxia in a human melanoma xenograft to exploit the bioreductive cytotoxicity of RSU-1069.
    Cole S; Stratford IJ; Adams GE
    Int J Radiat Biol; 1989 Nov; 56(5):587-91. PubMed ID: 2573651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.